Amarin Corp PLC (AMRN)
0.9255
+0.03
(+3.18%)
USD |
NASDAQ |
Apr 17, 16:00
0.9255
0.00 (0.00%)
After-Hours: 20:00
Amarin Market Cap: 371.45M for April 17, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 16, 2024 | 360.02M |
| April 15, 2024 | 368.68M |
| April 12, 2024 | 384.10M |
| April 11, 2024 | 409.38M |
| April 10, 2024 | 417.41M |
| April 09, 2024 | 425.44M |
| April 08, 2024 | 429.45M |
| April 05, 2024 | 421.42M |
| April 04, 2024 | 425.44M |
| April 03, 2024 | 425.44M |
| April 02, 2024 | 397.34M |
| April 01, 2024 | 353.99M |
| March 28, 2024 | 357.53M |
| March 27, 2024 | 356.88M |
| March 26, 2024 | 347.57M |
| March 25, 2024 | 338.70M |
| March 22, 2024 | 345.04M |
| March 21, 2024 | 345.77M |
| March 20, 2024 | 360.02M |
| March 19, 2024 | 348.18M |
| March 18, 2024 | 335.93M |
| March 15, 2024 | 344.72M |
| March 14, 2024 | 329.87M |
| March 13, 2024 | 346.37M |
| March 12, 2024 | 346.97M |
| Date | Value |
|---|---|
| March 11, 2024 | 359.53M |
| March 08, 2024 | 370.49M |
| March 07, 2024 | 372.06M |
| March 06, 2024 | 380.97M |
| March 05, 2024 | 377.71M |
| March 04, 2024 | 370.85M |
| March 01, 2024 | 425.44M |
| February 29, 2024 | 429.45M |
| February 28, 2024 | 529.79M |
| February 27, 2024 | 541.83M |
| February 26, 2024 | 485.64M |
| February 23, 2024 | 477.61M |
| February 22, 2024 | 484.59M |
| February 21, 2024 | 478.43M |
| February 20, 2024 | 488.70M |
| February 16, 2024 | 494.68M |
| February 15, 2024 | 498.77M |
| February 14, 2024 | 482.41M |
| February 13, 2024 | 461.97M |
| February 12, 2024 | 494.68M |
| February 09, 2024 | 498.77M |
| February 08, 2024 | 502.85M |
| February 07, 2024 | 490.59M |
| February 06, 2024 | 502.85M |
| February 05, 2024 | 482.41M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
269.47M
Minimum
Nov 02 2023
8.657B
Maximum
Dec 13 2019
2.225B
Average
1.627B
Median
Nov 11 2021
Market Cap Benchmarks
| Trinity Biotech PLC | 69.92M |
| DBV Technologies SA | 131.02M |
| Adaptimmune Therapeutics PLC | 243.99M |
| Akari Therapeutics PLC | 8.875M |
| Biodexa Pharmaceuticals Plc | 3.576M |
Market Cap Related Metrics
| PS Ratio | 1.229 |
| Price to Book Value | 0.6728 |
| Price to Free Cash Flow | 59.44 |
| Price | 0.9255 |
| Earnings Yield | -16.21% |